This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a piperazine ring and a benzyl group, makes it a valuable building block for developing drugs targeting the central nervous system, particularly those used in the treatment of psychiatric and neurological disorders. Additionally, it serves as a key precursor in the production of compounds with potential antimicrobial and anticancer properties. Its role in facilitating the creation of chiral molecules is also significant, as it aids in the development of enantiomerically pure drugs, enhancing their efficacy and reducing side effects.